PDF Publication Title:
Text from PDF Page: 014
Drug Combinations Evoke Collateral Sensitivity against ABCG2 292, 504 –514 35. Schaffner, W., and Weissmann, C. (1973) A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56, 502–514 36. Leach, F. R., and Webster, J. J. (1986) Commercially available firefly lucif- erase reagents. Methods Enzymol. 133, 51–70 37. Shukla, S., Robey, R. W., Bates, S. E., and Ambudkar, S. V. (2006) The calcium channel blockers, 1,4-dihydropyridines, are substrates of the mul- tidrug resistance-linked ABC drug transporter, ABCG2. Biochemistry 45, 8940 – 8951 38. Godfraind, T., and Ghysel-Burton, J. (1977) Binding sites related to oua- bain-induced stimulation or inhibition of the sodium pump. Nature 265, 165–166 39. Hagen, P. (1939) The effects of digilanid C in varying dosage upon the potassium and water content of rabbit heart muscle. J. Pharmacol. Exp. Ther. 67, 50 –55 40. Oselkin, M., Tian, D., and Bergold, P. J. (2010) Low-dose cardiotonic ste- roids increase sodium-potassium ATPase activity that protects hip- pocampal slice cultures from experimental ischemia. Neurosci. Lett. 473, 67–71 41. Hoffman, M. M., Wei, L. Y., and Roepe, P. D. (1996) Are altered pHi and membrane potential in huMDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J. Gen. Physiol. 108, 295–313 42. Stankovic, C. J., Heinemann, S. H., Delfino, J. M., Sigworth, F. J., and Schreiber, S. L. (1989) Transmembrane channels based on tartaric acid- gramicidin A hybrids. Science 244, 813– 817 43. Anner, B. M., and Moosmayer, M. (1994) Na,K-ATPase characterized in artificial membranes. 2. Successive measurement of ATP-driven Rb-accu- mulation, ouabain-blocked Rb-flux and palytoxin-induced Rb-efflux. Mol. Membr. Biol. 11, 247–254 44. Rottenberg, H., and Koeppe, R. E., 2nd. (1989) Mechanism of uncoupling of oxidative phosphorylation by gramicidin. Biochemistry 28, 4355– 4360 45. Harold, F. M., and Baarda, J. R. (1967) Gramicidin, valinomycin, and cat- ion permeability of Streptococcus faecalis. J. Bacteriol. 94, 53– 60 46. Wallace, K. B., and Starkov, A. A. (2000) Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 40, 353–388 47. Woodward, G. E., and Hudson, M. T. (1954) The effect of 2-desoxy-D- glucose on glycolysis and respiration of tumor and normal tissues. Cancer Res. 14, 599 – 605 48. Laberge, R. M., Ambadipudi, R., and Georges, E. (2009) P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. Arch. Biochem. Biophys. 491, 53– 60 49. al-Shawi, M. K., and Senior, A. E. (1993) Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J. Biol. Chem. 268, 4197– 4206 50. Litman, T., Zeuthen, T., Skovsgaard, T., and Stein, W. D. (1997) Structure- activity relationships of P-glycoprotein interacting drugs: kinetic charac- terization of their effects on ATPase activity. Biochim. Biophys. Acta 1361, 159 –168 51. Andreyev, A. Y., Kushnareva, Y. E., and Starkov, A. A. (2005) Mitochon- drial metabolism of reactive oxygen species. Biochemistry 70, 200 –214 52. Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., and Robinson, J. P. (2003) Mitochondrial complex I inhibitor rotenone in- duces apoptosis through enhancing mitochondrial reactive oxygen spe- cies production. J. Biol. Chem. 278, 8516 – 8525 53. Golstein, P., and Kroemer, G. (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32, 37– 43 54. Shi, Y. (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459 – 470 55. Fanciulli, M., Bruno, T., Giovannelli, A., Gentile, F. P., Di Padova, M., Rubiu, O., and Floridi, A. (2000) Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lo- nidamine. Clin. Cancer Res. 6, 1590 –1597 56. Linn, S. C., and Giaccone, G. (1995) MDR1/P-glycoprotein expression in colorectal cancer. Eur. J. Cancer 31A, 1291–1294 57. Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Ro- driguez, L., Kakarala, M., Carpenter, P. M., McLaren, C., Meyskens, F. L., Jr., and Brenner, D. E. (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. (Phila.) 4, 354 –364 58. Chen, J. Q., Contreras, R. G., Wang, R., Fernandez, S. V., Shoshani, L., Russo, I. H., Cereijido, M., and Russo, J. (2006) Sodium/potassium ATPase (Na ,K -ATPase) and ouabain/related cardiac glycosides: A new para- digm for development of anti-breast cancer drugs? Breast Cancer Res. Treat. 96, 1–15 31410 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289 • NUMBER 45 • NOVEMBER 7, 2014PDF Image | Curcumin with Either Gramicidin or Ouabain
PDF Search Title:
Curcumin with Either Gramicidin or OuabainOriginal File Name Searched:
PIIS0021925820333664.pdfDIY PDF Search: Google It | Yahoo | Bing
CO2 Organic Rankine Cycle Experimenter Platform The supercritical CO2 phase change system is both a heat pump and organic rankine cycle which can be used for those purposes and as a supercritical extractor for advanced subcritical and supercritical extraction technology. Uses include producing nanoparticles, precious metal CO2 extraction, lithium battery recycling, and other applications... More Info
Heat Pumps CO2 ORC Heat Pump System Platform More Info
| CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP |